We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+6.27%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$17.9B
AUM Growth
-$597M
(-3.2%)
Cap. Flow
-$1.32B
Cap. Flow
% of AUM
-7.36%
Top 10 Holdings %
Top 10 Hldgs %
8.81%
Holding
1,709
New
345
Increased
450
Reduced
603
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$146M |
| 2 |
Apple
AAPL
|
+$129M |
| 3 |
Tesla
TSLA
|
+$110M |
| 4 |
Medtronic
MDT
|
+$104M |
| 5 |
Verizon
VZ
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$181M |
| 2 |
Microsoft
MSFT
|
+$177M |
| 3 |
Comcast
CMCSA
|
+$173M |
| 4 |
Adobe
ADBE
|
+$163M |
| 5 |
Broadcom
AVGO
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Healthcare | 14.31% |
| 3 | Consumer Discretionary | 12.9% |
| 4 | Industrials | 11.52% |
| 5 | Financials | 10.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Elastic
ESTC
$8.02B
| $3.36M | 0.02% |
65,230
+49,476
| +314% | +$2.96M |
|
|
ICPT
802
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.35M | 0.02% |
270,441
-63,288
| -19% | -$896K |
|
803
Pliant Therapeutics
PLRX
$66.3M
| $3.34M | 0.02% |
172,990
+68,683
| +66% | +$1.44M |
|
804
Kforce
KFRC
$1.03B
| $3.34M | 0.02% |
60,945
+11,844
| +24% | +$684K |
|
805
GrafTech
EAF
$201M
| $3.33M | 0.02% |
69,949
-17,032
| -20% | -$827K |
|
806
Payoneer
PAYO
$2.41B
| $3.33M | 0.02% |
+608,180
| New | +$3.82M |
|
807
GATX Corp
GATX
$6.34B
| $3.32M | 0.02% |
31,221
-39,006
| -56% | -$4.06M |
|
|
SEM
808
DELISTED
Select Medical
SEM
| $3.32M | 0.02% |
248,155
-92,041
| -27% | -$1.19M |
|
809
Outset Medical
OM
$84.6M
| $3.31M | 0.02% |
8,551
+616
| +8% | +$174K |
|
810
Yum China
YUMC
$16.4B
| $3.3M | 0.02% |
+60,426
| New | +$3.07M |
|
|
PRVB
811
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $3.28M | 0.02% |
+310,693
| New | +$2.51M |
|
812
Federal Realty Investment Trust
FRT
$10.2B
| $3.27M | 0.02% |
32,402
+12,499
| +63% | +$1.27M |
|
813
Brady Corp
BRC
$4.48B
| $3.27M | 0.02% |
69,400
-16,861
| -20% | -$773K |
|
814
Brixmor Property Group
BRX
$9.12B
| $3.27M | 0.02% |
144,140
-359,610
| -71% | -$7.7M |
|
815
Dana Inc
DAN
$3.2B
| $3.25M | 0.02% |
+214,878
| New | +$3.33M |
|
816
The GEO Group
GEO
$4.14B
| $3.25M | 0.02% |
296,839
-123,736
| -29% | -$1.2M |
|
817
Granite Construction
GVA
$5.52B
| $3.24M | 0.02% |
92,514
-63,572
| -41% | -$2.08M |
|
|
ALLK
818
DELISTED
Allakos
ALLK
| $3.24M | 0.02% |
+384,976
| New | +$2.67M |
|
819
Omega Healthcare
OHI
$13.9B
| $3.24M | 0.02% |
115,965
-48,995
| -30% | -$1.48M |
|
820
RPC Inc
RES
$1.4B
| $3.23M | 0.02% |
363,503
-201,914
| -36% | -$1.82M |
|
821
Coupang
CPNG
$29.3B
| $3.22M | 0.02% |
+219,204
| New | +$3.87M |
|
822
Full Truck Alliance
YMM
$9.62B
| $3.21M | 0.02% |
+401,290
| New | +$2.75M |
|
823
Domo
DOMO
$184M
| $3.19M | 0.02% |
224,114
-8,600
| -4% | -$133K |
|
824
Gentherm
THRM
$1.27B
| $3.19M | 0.02% |
48,819
+400
| +0.8% | +$25.8K |
|
825
Cerence
CRNC
$391M
| $3.18M | 0.02% |
171,494
-88,080
| -34% | -$1.51M |
|
Similar funds
VAI
Voloridge Investment Management's Q4 2022 Portfolio in Review
As of Q4 2022, Voloridge Investment Management held 1,709 positions worth $17.9B, down 3.2% from $18.5B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
Voloridge Investment Management withdrew a net $1.32B in Q4 2022, closing 311 positions and reducing 603 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $181M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in Edwards Lifesciences worth $142M.
- Voloridge Investment Management's largest Q4 2022 buy was Edwards Lifesciences: 1,898,822 shares worth $142M.
- Voloridge Investment Management added most to Tesla in Q4 2022, an estimated $110M increase.
- Voloridge Investment Management's biggest Q4 2022 reduction was Microsoft, cutting an estimated $177M.
- Voloridge Investment Management fully exited Berkshire Hathaway Class B in Q4 2022, selling an estimated $181M.
- Voloridge Investment Management's ten largest holdings make up 8.8% of its $17.9B portfolio in Q4 2022.
- Voloridge Investment Management opened 345 new positions and closed 311 in Q4 2022.
- Voloridge Investment Management's portfolio value fell 3.2% quarter-over-quarter to $17.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.